Latest Breaking News On - Swagatam mukhopadhyay - Page 1 : comparemela.com

Creyon Bio gets some green for a new take on AI and genetic meds R&D

Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it’s technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.

San diegoUnited statesAl iskandariyahNorth carolinaResearch triangle parkChris hartSwagatam mukhopadhyayCreyon bioIonis pharmaceuticalsCasdin capitalAlexandria venture investmentsWeight lossMedical devicesHealthcare innovationMedcity newsMedcity news

Triangle Inno - New AI biotech with Triangle lab aims $40M at precision medicines

Triangle Inno - New AI biotech with Triangle lab aims $40M at precision medicines
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesAl iskandariyahChris hartSwagatam mukhopadhyayCreyon bioResearch triangle parkResearch triangleLux capitalCasdin capitalAlexandria venture investmentsSwag mukhopadyay

Creyon Bio Launches to Engineer Safe, Effective Precision Medicines on Demand for All Patients

/PRNewswire/ Creyon Bio, Inc. ("Creyon Bio"), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based.

Al iskandariyahMonica mcarthurZavain darDennis langerChris hartSwagatam mukhopadhyayCreyon bioCreyon bio incChief executive officerCreyon platformChief scientific officerCasdin capitalAlexandria venture investmentsChief scientificChief strategyChief technology

Creyon Bio Launches with $40 Million to Engineer Medicines on Demand for All

Creyon Bio Launches with $40 Million to Engineer Medicines on Demand for All
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Al iskandariyahZavain darDennis langerChris hartSwagatam mukhopadhyayCreyon bioCreyon platformLux capitalCasdin capitalAlexandria venture investmentsKiersten stead

Creyon Bio Secures $40M in Seed and Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

San diegoUnited statesAl iskandariyahMonica mcarthurZavain darDennis langerChris hartSwagatam mukhopadhyayCreyon bioResearch triangle parkLux capitalCasdin capitalAlexandria venture investmentsPresident chris hartChief scientific officer swagatam mukhopadhyayChief strategy